Search Results - "Pires, Luis A."

Left Ventricular-Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) by DOSHI, RAHUL N., DAOUD, EMILE G., FELLOWS, CHRISTOPHER, TURK, KYONG, DURAN, AURELIO, HAMDAN, MOHAMED H., PIRES, LUIS A.

“…Background: Chronic right ventricular pacing has been reported to promote cardiac dyssynchrony. The PAVE trial prospectively compared chronic biventricular…”
Get full text

Intraoperative Testing of the Implantable Cardioverter-Defibrillator: How Much Is Enough? by PIRES, LUIS A., JOHNSON, KATRINA M.

“…Introduction: Defibrillation testing of the implantable cardioverter‐defibrillator (ICD) is considered a standard and required practice at the time of…”
Get full text

Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS Complexes by Beshai, John F, Grimm, Richard A, Nagueh, Sherif F, Baker, James H, Beau, Scott L, Greenberg, Steven M, Pires, Luis A, Tchou, Patrick J

“…Cardiac-resynchronization therapy is beneficial in patients with heart failure and a prolonged QRS interval, but a new clinical trial showed that patients with…”
Get full text

Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study by BUXTON, Alfred E, LEE, Kerry L, HAFLEY, Gail E, PIRES, Luis A, FISHER, John D, GOLD, Michael R, JOSEPHSON, Mark E, LEHMANN, Michael H, PRYSTOWSKY, Eric N, ANDERSON, Kelley P

“…We determined the contribution of multiple variables to predict arrhythmic death and total mortality risk in patients with coronary disease and left…”
Get full text

Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis by van Bommel, Rutger J., Bax, Jeroen J., Abraham, William T., Chung, Eugene S., Pires, Luis A., Tavazzi, Luigi, Zimetbaum, Peter J., Gerritse, Bart, Kristiansen, Nina, Ghio, Stefano

“…Aims Predictors of Response to Cardiac Resynchronization Therapy (CRT) (PROSPECT) was the first large-scale, multicentre clinical trial that evaluated the…”
Get full text

Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom? by Pires, Luis A

“…The implantable cardioverter-defibrillator (ICD) has become an integral part of treatment for a variety of patients with symptomatic, or at risk for,…”
Get full text

Paced Left Ventricular QRS Width and ECG Parameters Predict Outcomes After Cardiac Resynchronization Therapy: PROSPECT-ECG Substudy by Hsing, Jeff M, Selzman, Kimberly A, Leclercq, Christophe, Pires, Luis A, McLaughlin, Michael G, McRae, Scott E, Peterson, Brett J, Zimetbaum, Peter J

“…BACKGROUND—For patients with symptomatic New York Heart Association class III or IV, ejection fraction ≤35%, and QRS ≥130 ms, cardiac resynchronization therapy…”
Get full text

Hydraulic characterization of earthworm macropore surfaces using miniaturized infiltration data by Villarreal, Rafael, Lozano, Luis A., Salazar, María Paz, Polich, Nicolás G., Bellora, Guido L., Ellerbrock, Ruth H., Pires Barbosa, Luis A., Gerke, Horst H., Soracco, C. Germán

Get full text

Left Ventricular Pacing Threshold and Outcome in MADIT-CRT by PIRES, LUIS A., MCNITT, SCOTT, SOLOMON, SCOTT, GOLDENBERG, ILAN, ZAREBA, WOJCIECH, MOSS, ARTHUR J.

“…LV Pacing Threshold and CRT Outcome Introduction High left ventricular (LV) pacing threshold (PT) may in some cases indicate the presence of scarred…”
Get full text

Failure of an ICD to Deliver Antitachycardia Therapy against Recurrent, Sustained Ventricular Tachycardia: What's the Mechanism? by WILLOUGHBY, MICHAEL C., DIAMANTAKOS, EVANGELOS, DORMAN, ANDREA K., PIRES, LUIS A.

Get full text

Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case by Pires-Luis, A., Montezuma, D., Vieira, J., Ramalho-Carvalho, J., Santos, C., Teixeira, M., Jerónimo, C., Henrique, R.

“…Hybrid oncocytic/chromophobe tumor (HOCT) is a renal cell neoplasm displaying overlapping cellular and architectural features of both renal oncocytoma (RO) and…”
Get full text

Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials by Pires, Luis A., Abraham, William T., Young, James B., Johnson, Katrina M.

“…Based on current patient selection criteria, a significant proportion of recipients of cardiac resynchronization therapy (CRT) do not respond to treatment. The…”
Get full text

Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study by Pires, Luís A., Hegg, Roberto, Valduga, Claudete J., Graziani, Sílvia R., Rodrigues, Débora G., Maranhão, Raul C.

“…Purpose In animal experiments paclitaxel oleate associated with a cholesterol-rich nanoemulsion concentrated in the neoplastic tissues and showed reduced…”
Get full text

Tissue removal by ultrasound evaluation (the TRUE study): the Jetstream G2 system post-market peripheral vascular IVUS study by Singh, Tejwant, Koul, Deepak, Szpunar, Susanna, Torey, James, Dhabuwala, Jigishu, Saigh, Lisa, Pires, Luis A, Davis, Thomas

“…Balloon angioplasty and stenting of infra-inguinal lesions is limited by poor long-term patency rates. Atherectomy decreases plaque burden and provides an…”
Get more information

Relation of ejection fraction and inducible ventricular Tachycardia to mode of death in patients with coronary artery disease: An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial by BUXTON, Alfred E, LEE, Kerry L, PRYSTOWSKY, Eric N, TALAJIC, Mario R, HAFLEY, Gail E, WYSE, D. George, FISHER, John D, LEHMANN, Michael H, PIRES, Luis A, GOLD, Michael R, PACKER, Douglas L, JOSEPHSON, Mark E

“…Fifty percent of deaths in patients with coronary disease occur suddenly. Although many factors correlate with increased mortality, there is little information…”
Get full text

Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy by Pires, Luis A

“…With chronic heart failure already an epidemic in the USA, its prevalence is expected to rise significantly in the future. Despite improved survival with…”
Get full text

Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure by Pires, Luis A, Ghio, Stefano, Chung, Eugene S, Tavazzi, Luigi, Abraham, William T, Gerritse, Bart

“…The long-term impact of cardiac resynchronization therapy (CRT)-induced acute improvement in left ventricular (LV) function is largely unknown. The goal of…”
Get more information

Estimation of the Optimal VV Delay by an IEGM-Based Method in Cardiac Resynchronization Therapy by MIN, XIAOYI, MEINE, MATHIAS, BAKER II, JAMES H., PIRES, LUIS A., TURK, KYONG T., HORN, EVELYN M., KOWAL, ROBERT C., PARIS, MICHAEL, PARK, EULJOON, FAIN, ERIC S.

“…Determination of the optimal interventricular (VV) delay in cardiac resynchronization therapy currently relies on costly, time‐consuming echocardiographic…”
Get full text

Worsening Heart Failure and Recurrent Untreated Ventricular Tachycardia in a CRT‐D Treated Patient: Why by JEFIC, DANE, ZEIN, AMINE M., JOHNSON, KATRINA M., PIRES, LUIS A.

Get full text

Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses by Pires, Luis A., Lehmann, Michael H., Steinman, Russell T., Baga, John J., Schuger, Claudio D.

“…Objectives. We sought to investigate the nature of terminal events and potential contributory clinical and nonclinical (e.g., device-related) factors…”
Get full text